Saturday, 20 January 2024 AstraZeneca Pharma India announced that it has received approval from the Central Drugs Standard Control Organisation for the import and marketing of Andexanet Alfa. The therapy addresses life-threatening or refractory bleeding associated with the use of Factor Xa (FXa) inhibitors, says a company statement.FXa inhibitors are increasingly employed for preventing and treating thrombotic events, such as deep vein thrombosis and pulmonary embolism, as well as in patients at high risk of stroke due to atrial fibrillation. While these medications effectively prevent unwanted clot formation, they also elevate the risk of major bleeding, which can be life-threatening.
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy. Sky News
AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering it unusable. This decision marks a significant development in the global vaccination effort against Covid-19.
#COVID19 #Astrazeneca #COVIDVaccine #Covishield #Worldnews #Indianews #UKCourt #Oneindia #Oneindianews
~PR.320~ED.102~
Saturday, 20 January 2024
![AstraZeneca requests European authorisation of Covid vaccine be pulled [Video]](https://video.newsserve.net/300/v/20240508/1375014316-AstraZeneca-requests-European-authorisation-of-Covid-vaccine-be.jpg)
![AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court [Video]](https://video.newsserve.net/300/v/20240508/1374973818-AstraZeneca-Withdraws-COVID-19-Vaccine-Globally-Days-After.jpg)
